304 related articles for article (PubMed ID: 30801261)
1. ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway.
Yuan Q; Cao S; Dong Q; Wang Z; Xu Y; Han Q; Ma J; Wei S; Pang J; Yang F; Zhang R; Liu B; Dai S; Xue L; Wang J; Xue M; Xu T; Zheng W; Xu F; Chen Y; Guo P
J Cardiovasc Pharmacol; 2019 Apr; 73(4):248-256. PubMed ID: 30801261
[TBL] [Abstract][Full Text] [Related]
2. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 2 protects against sympathetic excitation-induced cardiac fibrosis.
Yuan Q; Yang F; Dai S; Wang Z; Xu Y; Xu BC; Sun Y; Zheng B; Zhao Y; Wang W; Liu B; Wang J; Cui S; Cao S; Zhang R; Xue L; Wei S; Xue M; Xu T; Xu F; Chen Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1427-1434. PubMed ID: 33333711
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
5. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Peng H; Carretero OA; Peterson EL; Rhaleb NE
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
[TBL] [Abstract][Full Text] [Related]
6. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin modifies corneal fibroblast-to-myofibroblast differentiation.
Chen TC; Chang SW; Wang TY
Br J Pharmacol; 2013 Mar; 168(6):1341-54. PubMed ID: 23072440
[TBL] [Abstract][Full Text] [Related]
8. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
9. TGF-β
Salvarani N; Maguy A; De Simone SA; Miragoli M; Jousset F; Rohr S
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e004567. PubMed ID: 28500173
[TBL] [Abstract][Full Text] [Related]
10. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
[TBL] [Abstract][Full Text] [Related]
11. Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-β1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro.
Yang L; Hu J; Hao HZ; Yin Z; Liu G; Zou XJ
Int J Mol Med; 2015 Apr; 35(4):1026-32. PubMed ID: 25647570
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Suppresses TGF-B1-Induced Cardiac Myocyte Myofibroblast Transformation by Inhibiting Smad2/3 and Rhoa Signaling Pathways.
Yan Z; Shen D; Liao J; Zhang Y; Chen Y; Shi G; Gao F
Cell Physiol Biochem; 2018; 45(1):250-257. PubMed ID: 29357322
[TBL] [Abstract][Full Text] [Related]
13. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
[TBL] [Abstract][Full Text] [Related]
14. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of
Wen J; Lin X; Gao W; Qu B; Zuo Y; Liu R; Yu M
J Ocul Pharmacol Ther; 2019; 35(6):331-340. PubMed ID: 31343394
[No Abstract] [Full Text] [Related]
16. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
17. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
[TBL] [Abstract][Full Text] [Related]
18. NLRP1 promotes TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Zong J; Zhang H; Li FF; Liang K; Liu JL; Xu LH; Qian WH
J Mol Histol; 2018 Oct; 49(5):509-518. PubMed ID: 30120609
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
20. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
